FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Pfizer Aminophylline Injection Recall

Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only…

Pfizer Inc. · New York, NY

Risk level
Class II
Reported by FDA
Oct 12, 2022
Recall ID
D-0003-2023
Check your lot numberHow we source this data

Summary

Pfizer recalled Aminophylline Injection starting Sep 27, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0003-2023 on Oct 12, 2022. Reason: Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial. Status: Terminated.

Why it was recalled

Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.

Product description

Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. NDC 0409-5921-16 (vial) 0409-5921-01 (carton)

Lot numbers, UPCs & expiration codes

Lot: 30-137-DK Exp. 1 DEC. 2022

Where it was sold

Distributed in the United States and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0003-2023
Classification
Class II
Status
Terminated
Recall initiated
Sep 27, 2022
FDA report date
Oct 12, 2022
Quantity
103,150 10 mL vials
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Inc.

Original FDA data

Every field from FDA enforcement report D-0003-2023, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
90903
Address
235 East 42nd Street
Code information
Lot: 30-137-DK Exp. 1 DEC. 2022
Postal code
10017-5703
Report date
Oct 12, 2022
Product type
Drugs
Recall number
D-0003-2023
Classification
Class II
Recalling firm
Pfizer Inc.
Product quantity
103,150 10 mL vials
Termination date
Aug 21, 2024
Reason for recall
Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. NDC 0409-5921-16 (vial) 0409-5921-01 (carton)
Distribution pattern
Distributed in the United States and Puerto Rico.
Recall initiation date
Sep 27, 2022
Initial firm notification
Letter
Center classification date
Oct 4, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0003-2023, published Oct 12, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls